Literature DB >> 29857829

Correlation of clinical data with fallopian tube specimen immune cells and tissue culture capacity.

Satish Kumar Ramraj1, Katie M Smith2, Naveena B Janakiram3, Coralee Toal4, Ankita Raman5, Doris Mangiaracina Benbrook6.   

Abstract

Human fallopian tube fimbria secretory epithelial cells (hFTSECs) are considered an origin of ovarian cancer and methods for their culture from fallopian tube specimens have been reported. Our objective was to determine whether characteristics of the donors or surgeries were associated with the capacities of fimbria specimens to generate hFTSEC cultures or their immune profiles. There were no surgical complications attributable to fallopian tube removal. Attempts to establish primary hFTSEC cultures were successful in 37 of 55 specimens (67%). Success rates did not differ significantly between specimens grouped by patient or surgery characteristics. Established cultures could be revived after cryopreservation and none became contaminated with microorganisms. Two cultures evaluated for long term growth senesced between passages 10 and 15. M1 macrophages were the predominant cell type, while all other immune cells were present at much lower percentages. IL-10 and TGF-β exhibited opposing trends with M1 and M2 macrophages. Plasma IL-10 levels exhibited significant positive correlation with patient age. In conclusion, fallopian tube fimbria specimens exhibit a pro-inflammatory phenotype and can be used to provide a source of hFTSECs that can be cultured for a limited time regardless of the donor patient age or race, or the type of surgery performed.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokines; Fallopian tube fimbria; Human fallopian tube secretory epithelial cell cultures; Infiltrating immune cells; Salpingectomy

Mesh:

Year:  2018        PMID: 29857829      PMCID: PMC5986091          DOI: 10.1016/j.tice.2018.04.001

Source DB:  PubMed          Journal:  Tissue Cell        ISSN: 0040-8166            Impact factor:   2.466


  26 in total

1.  Aging is associated with circulating cytokine dysregulation.

Authors:  Lorena Alvarez-Rodríguez; Marcos López-Hoyos; Pedro Muñoz-Cacho; Víctor Manuel Martínez-Taboada
Journal:  Cell Immunol       Date:  2012-01-12       Impact factor: 4.868

2.  Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

Authors:  David W Kindelberger; Yonghee Lee; Alexander Miron; Michelle S Hirsch; Colleen Feltmate; Fabiola Medeiros; Michael J Callahan; Elizabeth O Garner; Robert W Gordon; Chandler Birch; Ross S Berkowitz; Michael G Muto; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

Review 3.  New insights into chronic inflammation-induced immunosuppression.

Authors:  Julia Kanterman; Moshe Sade-Feldman; Michal Baniyash
Journal:  Semin Cancer Biol       Date:  2012-02-24       Impact factor: 15.707

4.  Emerging roles for PAX8 in ovarian cancer and endosalpingeal development.

Authors:  Nathan J Bowen; Sanjay Logani; Erin B Dickerson; Laura B Kapa; Mariam Akhtar; Benedict B Benigno; John F McDonald
Journal:  Gynecol Oncol       Date:  2006-10-24       Impact factor: 5.482

5.  Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.

Authors:  Jessica N McAlpine; Gillian E Hanley; Michelle M M Woo; Alicia A Tone; Nirit Rozenberg; Kenneth D Swenerton; C Blake Gilks; Sarah J Finlayson; David G Huntsman; Dianne M Miller
Journal:  Am J Obstet Gynecol       Date:  2014-01-09       Impact factor: 8.661

6.  Three-dimensional modeling of the human fallopian tube fimbriae.

Authors:  Sharon L Eddie; Suzanne M Quartuccio; Jie Zhu; Jessica A Shepherd; Rajul Kothari; J Julie Kim; Teresa K Woodruff; Joanna E Burdette
Journal:  Gynecol Oncol       Date:  2014-12-16       Impact factor: 5.482

Review 7.  Aging and cancer: The role of macrophages and neutrophils.

Authors:  Connie Jackaman; Federica Tomay; Lelinh Duong; Norbaini Bintu Abdol Razak; Fiona J Pixley; Pat Metharom; Delia J Nelson
Journal:  Ageing Res Rev       Date:  2017-04-06       Impact factor: 10.895

Review 8.  Immune responses to malignancies.

Authors:  Theresa L Whiteside
Journal:  J Allergy Clin Immunol       Date:  2010-01-12       Impact factor: 10.793

Review 9.  Modulation of the immune response by transforming growth factor beta.

Authors:  A Fontana; D B Constam; K Frei; U Malipiero; H W Pfister
Journal:  Int Arch Allergy Immunol       Date:  1992       Impact factor: 2.749

10.  In vitro three-dimensional modeling of fallopian tube secretory epithelial cells.

Authors:  Kate Lawrenson; Maria Notaridou; Nathan Lee; Elizabeth Benjamin; Ian J Jacobs; Christopher Jones; Simon A Gayther
Journal:  BMC Cell Biol       Date:  2013-09-27       Impact factor: 4.241

View more
  2 in total

1.  Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53.

Authors:  Satish K Ramraj; Sugantha P Elayapillai; Richard C Pelikan; Yan D Zhao; Zitha R Isingizwe; Amy L Kennedy; Stanley A Lightfoot; Doris M Benbrook
Journal:  Int J Cancer       Date:  2020-01-08       Impact factor: 7.396

Review 2.  Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance.

Authors:  Łukasz Zadka; Damian J Grybowski; Piotr Dzięgiel
Journal:  Cell Oncol (Dordr)       Date:  2020-06-02       Impact factor: 6.730

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.